Plant Health Care Full Year 2023 Earnings: EPS Beats Expectations

Plant Health Care (LON:PHC) Full Year 2023 Results

Key Financial Results

• Revenue: US$11.2m (down 4.8% from FY 2022).
• Net loss: US$4.00m (loss narrowed by 58% from FY 2022).
• US$0.01 loss per share (improved from US$0.031 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Plant Health Care EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.0%.

Looking ahead, revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 6.0% decline forecast for the Chemicals industry in the United Kingdom.

Performance of the British Chemicals industry.

The company's shares are up 20% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 4 warning signs for Plant Health Care you should be aware of, and 1 of them makes us a bit uncomfortable.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.